Endothelial cells as target for antiphospholipid antibodies: Human polyclonal and monoclonal anti-β2-glycoprotein I antibodies react in vitro with endothelial cells through adherent β2-glycoprotein I and induce endothelial activation

Arthritis and Rheumatism

Volumn 40, Issue 3, 1997, Pages 551-561

  Del Papa, N ^a   Guidali, L ^a   Sala, A ^a   Buccellati, C ^a   Khamashta, M A ^b   Ichikawa, K ^c   Koike, T ^c   Balestrieri, G ^d   Tincani, A ^d   Hughes, G R V ^b   Meroni, P L ^a,e  

^a UNIVERSITY OF MILAN   (Italy)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c HOKKAIDO UNIVERSITY   (Japan)

^d SPEDALI CIVILI   (Italy)

^e FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; GLYCOPROTEIN; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 6; MONOCLONAL ANTIBODY; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BINDING AFFINITY; CELL KINETICS; CLINICAL ARTICLE; ENDOTHELIUM CELL; FEMALE; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; MALE; PRIORITY JOURNAL; THROMBOGENESIS; THROMBOSIS;

6-KETOPROSTAGLANDIN F1 ALPHA; ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIBODIES, MONOCLONAL; ANTIPHOSPHOLIPID SYNDROME; APOLIPOPROTEINS; BETA 2-GLYCOPROTEIN I; CELL ADHESION; CELL ADHESION MOLECULES; CELLS, CULTURED; CHROMATOGRAPHY, AFFINITY; ENDOTHELIUM, VASCULAR; EPITOPES; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN-6; MALE; PROTEIN BINDING; UMBILICAL VEINS;

EID: 0030897237     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780400322     Document Type: Article

References (55)

1. Khamashta MA, Asherson RA: Hughes syndrome: antiphospholipid antibodies move closer to thrombosis in 1994. Br J Rheumatol 34:493-494, 1995
2. Carreras LO, Defreyn G, Machin SJ: Arterial thrombosis, intrauterine death and "lupus" anticoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet i:244-246, 1981
3. Carreras LO, Vermylen JG: Lupus anticoagulant and thrombosis: possible role of inhibition of prostacyclin formation. Thromb Haemost 48:38-40, 1982
4. Triplett DA: Antiphospholipid antibodies: proposed mechanisms of action. Am J Reprod Immunol 28:211-215, 1982
5. Vermylen JG, Arnout J: Is the antiphospholipid syndrome caused by antibodies directed against physiologically relevant phospholipid-protein complex? J Lab Clin Med 120:10-12, 1992
6. Meroni PL, Del Papa N, Gambini D, Tincani A, Balestrieri G: Antiphospholipid antibodies and endothelial cells. Lupus 3:267-269, 1994
7. Vismara A, Meroni PL, Tincani A, Harris EN, Barcellini W, Brucato A, Khamashta MA, Hughes GRV, Zanussi C, Balestrieri G: Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus. Clin Exp Immunol 74:247-253, 1988
8. Hasselaar P, Derksen RHW, Blokzijl L, De Groot PG: Cross-reactivity of antibodies directed against cardiolipin, DNA, endo thelial cells and blood platelets. Thromb Haemost 63:169-173, 1990
9. Del Papa N, Meroni PL, Tincani A, Harris EN, Pierangeli SS, Barcellini W, Borghi MO, Balestrieri G, Zanussi C: Relationship between antiphospholipid and antiendothelial antibodies: further characterization of the reactivity on resting and cytokine-activated endothelial cells. Clin Exp Rheumatol 10:37-42, 1992
10. McGrae KR, De Michele A, Samuels P, Roth D, Kuo A, Meg QH, Rauch J, Cines DA: Detection of endothelial cell reactive immunoglobulin in patients with anti-phospholipid antibodies. Br J Haematol 79:595-605, 1991
11. Cervera R, Khamashta MA, Font J, Ramirez J, D' Cruz D, Montalban J, Lopez-Soto A, Asherson RA, Ingelmo M, Hughes GRV: Antiendothelial cell antibodies in patients with the antiphospholipid syndrome. Autoimmunity 11:1-6, 1991
12. Del Papa N, Conforti G, Gambini D, La Rosa L, Tincani A, D'Cruz D, Khamashta MA, Hughes GRV: Characterization of the endothelial surface proteins recognized by anti-endothelial anti-bodies in primary and secondary autoimmune vasculitis. Clin Immunol Immunopathol 70:211-216, 1994
13. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA: Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A 87:4120-4124, 1990
14. Galli M, Comfurius P, Maasen C, Hemker HC, de Baets MH, van Breida-Vrieasman PJC, Barbui T, Beevers EM: Anticardiolipin antibodies (ACA) are directed not to cardiolipin but to a plasma protein cofactor. Lancet 335:1544-1547, 1990
15. Arvieaux J, Roussel B, Jacob MC, Columb MG: Measurement of anti-phospholipid antibodies by ELISA using β2-glycoprotein I as antigen. J Immunol Methods 143:223-229, 1991
16. Viard JP, Amoura Z, Bach JF: Association of anti-β2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 93:181-186, 1992
17. Cabiedes J, Cabral AR, Alarcon Segovia D: Clinical manifestations of anti-phospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-β2glycoprotein I than with anti-phospholipid antibodies. J Rheumatol 22:1899-1906, 1995
18. Balestrieri G, Tincani A, Spatola L, Allegri F, Prati E, Cattaneo R, Valesini G, Del Papa N, Meroni PL: Anti-β2 glycoprotein I antibodies: a marker of anti-phospholipid syndrome. Lupus 4:122-130, 1995
19. Martinuzzo ME, Forastiero RR, Carerras LO: Anti-β2 glycoprotein I antibodies: detection and association with thrombosis. Br J Haematol 89:397-402, 1995
20. Roubey RAS: Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulant and other "antiphospholipid" autoantibodies. Blood 84:2854-2867, 1994
21. Roubey RAS, Eisenberg RA, Harper MF, Winfield JB: Anticardiolipin autoantibodies recognize β2-glycoprotein I in the absence of phospholipid. J Immunol 154:954-960, 1995
22. Ichikawa K, Khamashta MA, Koike T, Matsuura E, Hughes GRV: β2-glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome. Arthritis Rheum 37:1453-1461, 1994
23. Schousboe I: β2-glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood 66: 1086-1091, 1985
24. Nimpf J, Bevers EM, Bomans PH: Prothrombinase activity of human platelets is inhibited by β2-glycoprotein I. Biochim Biophys Acta 884:142-149, 1986
25. Nimpf J, Wurm H, Kostner GM: β2-glycoprotein I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation. Atherosclerosis 63:109-114, 1987
26. Vazquez-Mellado J, Llorente L, Richaud-Patin Y, Alarcon Segovia D: Exposure of anionic phospholipids upon platelet activation permits binding of β2 glycoprotein I and through it that of IgG antiphospholipid antibodies: studies in platelets from patients with antiphospholipid syndrome and normal subjects. J Autoimmun 12:122-131, 1994
27. Del Papa N, Conforti G, Gambini D, Barcellini W, Borghi MO, Fain C, Tincani A, Balestrieri G, Tedesco F, Meroni PL: Characterisation of antiendothelial cell antibodies in antiphospholipid syndrome. In, Molecular Basis of Human Diseases. Edited by EE Polli. Amsterdam, Excerpta Medica, 1993
28. Me Intyre JA: Immune recognition at the maternal-fetal interface: overview. Am J Reprod Immunol 28:127-131, 1992
29. La Rosa L, Meroni PL, Tincani A, Balestrieri G, Faden A, Lojacono A, Morassi L, Brocchi E, Del Papa N, Gharavi AE, Sammaritano L, Lockshin MD: β2-glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome. J Rheumatol 21:1684-1698, 1994
30. Del Papa N, Guidali L, Spatola L, Bonara P, Borghi MO, Tincani A, Balestrieri G, Meroni PL: Relationship between antiphospholipid and anti-endothelial antibodies. III. β2-glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules. Clin Exp Rheumatol 13:179-186, 1995
31. Simantov R, LaSala JM, Lo SK, Gharavi AE, Sammaritano LR, Salmon JE, Silverstein RL: Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest 96:2211-2219, 1995
32. Tincani A, Meroni PL, Brucato A, Zanussi C, Allegri F, Mantelli P, Cattaneo R, Balestrieri G: Antiphospholipid and anti-mitochondrial type M5 antibodies in SLE. Clin Exp Rheumatol 3:321-326, 1985
33. Del Papa N, Guidali L, Sironi M, Shoenfeld Y, Mantovani A, Tincani A, Balestrieri G, Radice A, Sinico RA, Meroni PL: Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. Arthritis Rheum 39:758-766, 1996
34. Ter Borg EJ, Horst G, Hummel EJ, Limburg PC, Kallenberg CGM: Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus: a long-term, prospective study. Arthritis Rheum 33:634-643, 1990
35. Sironi M, Breviario F, Proserpio P, Biondi A, Vecchi A, van Damme J, Dejana E, Mantovani A: IL-1 stimulates IL-6 production in endothelial cells. J Immunol 142:549-553, 1989
36. 2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci U S A 83:9679-9685, 1986
37. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-61, 1983
38. Pradelles P, Grassi J, Maclouf J: Enzyme immunoassays of eico sanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal Chem 57:1170-1174, 1985
39. Carlos TM, Harlan JM: Leukocyte-endothelial adhesion molecules. Blood 84:2068-2101, 1994
40. Bevers EM, Galli M: Cofactors involved in the antiphospholipid syndrome. Lupus 1:51-52, 1992
41. Matsuura E, Igarashi Y, Yasuda Y, Triplett DA, Koike T: Anti-cardiolipin antibodies recognize β2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 179:457-462, 1994
42. Matsuura E, Igarashu Y, Fujimoto M, Ichikawa K, Koike T: Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 336:177-178, 1990
43. Pengo V, Biasiolo A, Fior MG: Autoimmune phospholipid antibodies are directed against a cryptic epitope expressed when β2-glycoprotein I is bound to a suitable surface. Thromb Haemost 73:29-34, 1995
44. Carvalho D, Savage COS, Black CM, Pearson JD: IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. J Clin Invest 97:111-119, 1996
45. Dunky A, Neumüller J, Wagner E, Menzel J: In vitro interactions between lymphocytes and endothelial cells in psoriatic arthritis (abstract). Arthritis Rheum 38 (suppl 9):S158, 1995
46. Arnout J: The pathogenesis of the antiphospholipid syndrome: a hypothesis based on parallelisms with heparin-induced thrombocytopenia. Thromb Haemost 75:536-541, 1996
47. Nawrot P, Stern D: Endothelial cell procoagulant properties and the host response. Semin Thromb Hemost 13:391-398, 1987
48. Kornberg A, Blank M, Kaufman S, Shoenfeld Y: Induction of tissue factor-like activity in monocytes by anticardiolipin antibodies. J Immunol 153:1328-1331, 1994
49. Alarcon-Segovia D, Cardiel MH, Reyes E: Antiphospholipid arterial vasculopathy. J Rheumatol 16:762-767, 1989
50. Goldberger E, Elder RC, Schwartz RA, Phillips PE: Vasculitis in the antiphospholipid syndrome: a cause of ischemia responding to corticosteroids. Arthritis Rheum 35:569-572, 1992
51. Roberts WN, De Meo JH, Breitbach SA: Well-imaged large vessel vasculitis attributed to anticardiolipin antibody. Arthritis Rheum 37:1254-1257, 1994
52. Lie JT: Vasculitis in the antiphospholipid syndrome: culprit or consort? J Rheumatol 21:397-399, 1994
53. Carreras LA, Maclouf J: Antiphospholipid antibodies and eicosanoids. Lupus 3:271-273, 1994
54. Lellouche F, Martinuzzo ME, Said P, Maclouf J, Carreras LA: Imbalance of thromboxane/prostacyclin biosynthesis in patients with lupus anticoagulant. Blood 78:2894-2899, 1991
55. Habib A, Martinuzzo M, Lebret M, Levy-Toledano S, Carreras LO, Maclouf J: Lupus anticoagulant IgGs do not depend on serum for the induction of cyclooxygenase-2 by human endothelial cells. In, Advances in Prostaglandin, Thromboxane, and Leukotriene Research. Edited by B Samuelsson, R Paoletti, E Granstrom, PW Ramwell, G Folco, S Nicosia. New York, Raven Press, 1993